Inventor · disambiguated record
Rami El-Hayek
Also filed as: EL-HAYEK RAMI
18 granted patents·16 pending applications·173 citations·filing 2011–2025
94Inventor score
Top patents by PatentIndex Score
34 records- 0198US9205150B2Medical organogel processes and compositionsINCEPT LLC·Filed 2012·Granted Dec 8, 2015·50 cites·54 claims
- 0297US10905765B2Medical organogel processes and compositionsINCEPT LLC·Filed 2015·Granted Feb 2, 2021·16 cites·16 claims
- 0396US11331267B2Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporineOCULAR THERAPEUTIX INC·Filed 2021·Granted May 17, 2022·5 cites·23 claims
- 0496US11291627B1Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporineOCULAR THERAPEUTIX INC·Filed 2021·Granted Apr 5, 2022·6 cites·23 claims
- 0596US10786462B2Shape changing drug delivery devices and methodsINCEPT LLC·Filed 2019·Granted Sep 29, 2020·25 cites·24 claims
- 0696US10420724B2Shape changing drug delivery devices and methodsINCEPT LLC·Filed 2016·Granted Sep 24, 2019·29 cites·25 claims
- 0795US11534396B2Methods of treatment with an ocular implant containing a tyrosine kinase inhibitorOCULAR THERAPEUTIX INC·Filed 2022·Granted Dec 27, 2022·9 cites·29 claims
- 0894US12161753B2Sustained release biodegradable intracanalicular inserts comprising a hydrogel and an active agentOCULAR THERAPEUTIX INC·Filed 2021·Granted Dec 10, 2024·2 cites·26 claims
- 0994US11439592B2Ocular implant containing a tyrosine kinase inhibitorOCULAR THERAPEUTIX INC·Filed 2021·Granted Sep 13, 2022·6 cites·27 claims
- 1092US11779536B2Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporineOCULAR THERAPEUTIX INC·Filed 2022·Granted Oct 10, 2023·1 cites·20 claims
- 1192US11369591B2Drug delivery from hydrogelsINCEPT LLC·Filed 2016·Granted Jun 28, 2022·5 cites·21 claims
- 1291US10226417B2Drug delivery systems and applicationsJARRETT PETER·Filed 2011·Granted Mar 12, 2019·18 cites·40 claims
- 1390US12357565B2Ocular implant containing a tyrosine kinase inhibitorOCULAR THERAPEUTIX INC·Filed 2022·Granted Jul 15, 2025·1 cites·10 claims
- 1485US2025057759A1Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporineOCULAR THERAPEUTIX INC·Filed 2024·Application pending·0 cites
- 1584US12109302B2Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporineOCULAR THERAPEUTIX INC·Filed 2023·Granted Oct 8, 2024·0 cites·20 claims
- 1680US11938223B2Shape changing drug delivery devices and methodsINCEPT LLC·Filed 2022·Granted Mar 26, 2024·0 cites·20 claims
- 1780US2024285518A1Ocular hydrogel tyrosine kinase inhibitor implantsOCULAR THERAPEUTIX INC·Filed 2024·Application pending·0 cites
- 1877US2025120906A1Sustained release biodegradable intracanalicular inserts comprising a hydrogel and an active agentOCULAR THERAPEUTIX INC·Filed 2024·Application pending·0 cites
- 1975US2023040637A1Ocular hydrogel tyrosine kinase inhibitor implantsOCULAR THERAPEUTIX INC·Filed 2022·Application pending·0 cites
- 2074US2025332094A1Ocular implant containing a tyrosine kinase inhibitorOCULAR THERAPEUTIX INC·Filed 2025·Application pending·0 cites
- 2173US11890343B2Medical organogel processes and compositionsINCEPT LLC·Filed 2020·Granted Feb 6, 2024·0 cites·19 claims
- 2271US11413250B2Shape changing drug delivery devices and methodsINCEPT LLC·Filed 2020·Granted Aug 16, 2022·0 cites·14 claims
- 2370US2023285282A1Ocular implant containing an active ingredientOCULAR THERAPEUTIX INC·Filed 2023·Application pending·0 cites
- 2469US2022370419A1Drug delivery from hydrogelsINCEPT LLC·Filed 2022·Application pending·0 cites
- 2565US2020337989A1Ocular hydrogel tyrosine kinase inhibitor implantsOCULAR THERAPEUTIX INC·Filed 2020·Application pending·0 cites
- 2664US12453724B2Ocular implant containing a tyrosine kinase inhibitorOCULAR THERAPEUTIX INC·Filed 2025·Granted Oct 28, 2025·0 cites·12 claims
- 2764US2023390189A1Ocular implant containing an active ingredientOCULAR THERAPEUTIX INC·Filed 2021·Application pending·0 cites
- 2862US2025092013A1Prodrugs of axitinibOCULAR THERAPEUTIX INC·Filed 2022·Application pending·0 cites
- 2961US2025064760A1Intracanalicular insert comprising a non-steroidal anti-inflammatory agentOCULAR THERAPEUTIX INC·Filed 2023·Application pending·0 cites
- 3059US2024042713A1Extruded ocular inserts or implants and methods thereofOCULAR THERAPEUTIX INC·Filed 2022·Application pending·0 cites
- 3158US2019167573A1Drug delivery systems and applicationsINCEPT LLC·Filed 2018·Application pending·0 cites
- 3249US2020337993A1Intracanalicular hydrogel inserts for the delivery of anestheticsOCULAR THERAPEUTIX INC·Filed 2020·Application pending·0 cites
- 3344US2016166504A1Hydrogel drug delivery implantsINCEPT LLC·Filed 2015·Application pending·0 cites
- 3442US2016106587A1Ocular gels or hydrogels and microinjectorsINCEPT LLC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rami El-Hayek files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →